GlassScriptPhysician profile
Aaditya Shah
NPI 1124688221
$818.45
in general payments reported to CMS, 2019-2025
9 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2021: $116 · 2022: $24.50 · 2023: $87.65 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241 · Entertainment: $38.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.47 |
| Entertainment | $38.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $413.55 | 2019-2021 | |
| Allergan, INC. | $99.99 | 2019 | |
| Glaukos Corporation | $87.65 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $52.45 | 2025 | Eylea Hd |
| Apellis Pharmaceuticals, INC. | $43.00 | 2025 | Syfovre |
| Optos, INC. | $38.94 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Genentech USA, INC. | $33.15 | 2025 | Vabysmo |
| Abbvie INC. | $25.22 | 2025 | |
| Bausch & Lomb Americas INC. | $24.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaditya Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.